Home > Call For Paper > Recombinant Vaccine

Recombinant Vaccine

Recombinant vaccines are produced using genetic engineering, where genetic material from a pathogen is inserted into harmless vectors to express antigens. They are safe and effective, mimicking natural immune responses without causing disease. Examples include hepatitis B, HPV, and COVID-19 vaccines. Ongoing research aims to optimize production, enhance immunity, and develop vaccines against new pathogens and cancers. This technology represents a significant advancement in vaccine development, offering scalable, targeted, and safer alternatives to traditional vaccines.

  • Antigen production
  • Vector system
SUBMIT ABSTRACT
  +1-404-759-9729
Subscribe To Our Newsletter
175614
TOP